Senvest Management

Founded in 2012, Biolinq develops digital health platforms centered around skin-applied electronic biosensors. These minimally invasive sensors analyze biomarkers in interstitial fluid to provide real-time, actionable health information, initially focusing on continuous glucose monitoring for diabetic patients.

iAnthus Capital Holdings, Inc. is involved in the cannabis industry through its subsidiary, iAnthus Capital Management, LLC. The company offers investors diversified exposure to licensed cannabis cultivators, processors, and dispensaries across the United States. iAnthus has established ownership, operational control, or partnerships with marijuana license holders in several states, including Massachusetts, Vermont, Colorado, and New Mexico. By combining financial resources with operational expertise, iAnthus aims to support the growth of its partners in the legal cannabis market.

Founded in 2010, WATT Fuel Cell Corporation specializes in developing and manufacturing solid oxide fuel cell (SOFC) stacks and systems. These operate on readily available fuels like propane, natural gas, JP-8, and diesel to manage renewable power sources. The company offers hybrid SOFC systems that combine hydrocarbon fuels with solar or wind technologies for optimized power output, energy storage, and fuel consumption. WATT serves marine and RV, emergency response, military, and remote power sectors.

Tasso, Inc., established in 2012 and based in Seattle, Washington, specializes in manufacturing clinical-grade, at-home blood sample collection devices. Their innovative product allows patients to conveniently and painlessly collect their own blood at home using a simple, push-button mechanism, and then mail the samples to a qualified lab for analysis. This approach aims to enhance accessibility and comfort in blood-based diagnostics, reducing the need for clinic visits.

Founded in 2012, Biolinq develops digital health platforms centered around skin-applied electronic biosensors. These minimally invasive sensors analyze biomarkers in interstitial fluid to provide real-time, actionable health information, initially focusing on continuous glucose monitoring for diabetic patients.

Redwire, LLC specializes in the design, development, and manufacturing of spacecraft architecture and components. Founded in 2002 and based in Fulton, Maryland, the company emphasizes space commercialization and digitally engineered spacecraft. Redwire offers a range of services, including supply chain security assessments, anti-tamper engineering and packaging, deployment, and maintenance. The company aims to accelerate humanity's advancement into space by providing reliable and cost-effective infrastructure for future generations, with a focus on on-orbit services, assembly, and manufacturing. Redwire was formerly known as Adcole Maryland Aerospace before its name change in June 2020 following a merger with Deep Space Systems.

Otonomo Technologies Ltd. operates a cloud-based marketplace that connects cars to services and applications, facilitating the collection and delivery of vehicle data for enhanced safety and in-car experiences. The company, founded in 2015 and headquartered in Herzliya, Israel, with offices in Redwood City, California, and Frankfurt, Germany, securely processes over 4 billion data points daily from more than 40 million vehicles. Otonomo's platform enables original equipment manufacturers (OEMs), fleet operators, and over 100 service providers to access and utilize this data, accelerating the development of new services that improve driver experiences and support smart city initiatives. The company prioritizes privacy and neutrality, ensuring compliance with global data protection regulations.

Rockley Photonics Limited, founded in 2013 and based in London, United Kingdom, specializes in developing silicon photonics technologies for diverse applications. The company focuses on creating integrated optical modules, sensors, and comprehensive solutions that cater to high-volume and dynamic market sectors. Rockley aims to revolutionize mobile health monitoring and machine vision with its next-generation sensing platforms, while also providing high-speed solutions for data communications. By leveraging its innovative photonic integrated circuits and associated modules, Rockley is positioned to address a wide array of vertical applications, believing that photonics will become as ubiquitous as microelectronics in the future. The company combines hardware with supporting electronics, software, application algorithms, and AI platforms, establishing a robust foundation for future developments across multiple industries.

WM Technology provides the broadest suite of cloud-based software as a service (SaaS) and data solutions for the cannabis industry. WM Technology’s product suite includes point of sale, logistics, wholesale, and ordering solutions that enable clients to scale their businesses while complying with the complex and disparate regulations applicable to the cannabis industry.

AIStorm develops AI-in-sensor microchips for semiconductor companies. Its products include Mantis Family of AI-in-Imager and AI-in-Audio chips, and MantisNet AI videos. Applications span screen fingerprint sensors, augmented transportation, security cameras, gesture control, food service automation, medical imaging diagnosis, and edge voice processing.

Pharmacopeia, Inc. is a biopharmaceutical company focused on the discovery and development of therapeutics for unmet medical needs. The company's internal program portfolio includes PS433540, a dual-acting angiotensin and endothelin receptor antagonist currently in phase II clinical development for cardiovascular and renal diseases, such as hypertension and diabetic nephropathy. Additionally, PS178990, a muscle selective SARM agonist, is in phase I clinical development. Pharmacopeia also has a preclinical product, PS031291, aimed at treating multiple myeloma and inflammatory diseases like rheumatoid arthritis, as well as JAK3 inhibitors targeting T-cell and cytokine mediated dermatologic and ocular conditions, including psoriasis and dry eye. The company has formed strategic alliances with several pharmaceutical firms, enhancing its research and development capabilities. Founded in 1993 and based in Cranbury, New Jersey, Pharmacopeia was previously known as Pharmacopeia Drug Discovery, Inc. and became a subsidiary of Ligand Pharmaceuticals Inc. in 2008.